Drw Securities, LLC Cyma Bay Therapeutics, Inc. Transaction History

Drw Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $194,752 - $259,908	-17,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $9,594 - $12,942	900 Added 5.29%	17,900 $240,000
Q1 2018 May 14, 2018	BUY	$9.0 - $15.16 $45,000 - $75,800	5,000 Added 41.67%	17,000 $221,000
Q4 2017 Feb 14, 2018	SELL	$7.67 - $9.31 $61,360 - $74,480	-8,000 Reduced 40.0%	12,000 $110,000
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $119,000 - $165,200	20,000	20,000 $161,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.